C07D 499/883
With a substituted hydrocarbon radical attached in position 3
Official title: with a substituted hydrocarbon radical attached in position 3
C07D499/883 (With a substituted hydrocarbon radical attached in position 3) appears on 4 US grants and 6 published applications in this corpus.
Search patents in C07D- Granted patents
- 4
- Published applications
- 6
- Assignees
- 7
- Inventors
- 25
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 2 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Beta-lactam compounds and methods of use thereof12 May 2026US 12,624,382 B2The University of Hong Kong
- Fluorescence quenching immunoassay1 Jul 2025US 12,345,641 B2IDEZZ Laboratories, Inc.
- β-lactam-cannabinoid conjugate molecules25 Mar 2025US 12,257,307 B2Diverse Biotech, Inc.
- Compounds and their use12 Feb 2019US 10,201,532 B2Allecra Therapeutics SAS
- Beta-Lactam-Cannabinoid Conjugate Molecules10 Jul 2025US 2025/0222118 A1Diverse Biotech, Inc.
- Beta-Lactam-Cannabinoid Conjugate Molecules18 Aug 2022US 2022/0257778 A1Diverse Biotech, Inc.
- Fluorescence quenching immunoassay17 Mar 2022US 2022/0082501 A1IDEXX Laboratories, Inc.
- Beta-lactam compounds and methods of use thereof8 Jul 2021US 2021/0207188 A1The University of Hong Kong
- Compounds and their use27 Feb 2014US 2014/0057888 A1Allecra Therapeutics SAS
Most cited
By later US patents